Clinical trial
Topical 10% Lidocaine Spray for Reducing Injection Pain During Digital Nerve Block in Adults With Traumatic Finger Lacerations: A Randomized, Double-Blind, Placebo-Controlled, Two-Center Trial
NCT07834866 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Topical 10% Lidocaine Spray for Reducing Injection Pain During Digital Nerve Block in Adults With Traumatic Finger Lacerations: A Randomized, Double-Blind, Placebo-Controlled, Two-Center Trial
- Lead sponsor
- Ankara City Hospital Bilkent
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 1, 2026
- Completion date
- September 15, 2026
- Enrollment
- 240 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.